ANL
Adlai NortyeBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ANL vs peer average
56/100
ANL vs. peer average (B vs. B)
Grade spread
A 5 · B 2 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ALGS is the first available peer comparator.
Aligos is a loose small-cap biotech comp by size rather than mechanism; like ANL, valuation can swing sharply on clinical progress versus financing pressure.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANL
Adlai Nortye
ALGS
Aligos Therapeutics
Grade
B
A
Momentum
89
65
Value
41
57
Sentiment
43
64
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ALGS
ANL / ALGS
Grade Position
In line
ANL vs. peer average (B vs. B)
56/100
Momentum
89
ANLValue
41
ALGSSentiment
43
ALGSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANL
ALGS is the first peer returned for this comparison set.